These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31281864)

  • 21. Outcomes of Outpatient Parenteral Antimicrobial Therapy With Ceftriaxone for Methicillin-Susceptible
    Hamad Y; Connor L; Bailey TC; George IA
    Open Forum Infect Dis; 2020 Sep; 7(9):ofaa341. PubMed ID: 32908944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Options for Adult Patients With Persistent Methicillin-Susceptible
    Chastain DB; Covert KL; Tu PJ; McDougal S; White BP; Cluck D
    Ann Pharmacother; 2023 Nov; 57(11):1312-1327. PubMed ID: 36946576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Definitive Treatment for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Data Versus a Definitive Answer?
    Karchmer AW
    Clin Infect Dis; 2017 Jul; 65(1):107-109. PubMed ID: 28379366
    [No Abstract]   [Full Text] [Related]  

  • 24. Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.
    Lee BJ; Rao SN; Wang SK; Lee JY; Lakada IY; Gilbert EM; Barr VO; Postelnick MJ; Sutton SH; Zembower TR; Bolon M; Scheetz MH; Rhodes NJ
    Int J Antimicrob Agents; 2017 May; 49(5):650-654. PubMed ID: 28279787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective Analysis of Adverse Drug Events Between Nafcillin Versus Cefazolin for Treatment of Methicillin-Susceptible
    Chan L; Chan-Tompkins NH; Como J; Guarascio AJ
    Ann Pharmacother; 2020 Jul; 54(7):662-668. PubMed ID: 31888347
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of penicillins (penicillin G and ampicillin) and cefazolin as a definitive therapy against penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia in Japan: a retrospective cohort study.
    Moriyama Y; Ishikane M; Mezaki K; Ohmagari N
    J Infect Chemother; 2020 Apr; 26(4):358-362. PubMed ID: 31822451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerability of Cefazolin in Nafcillin-Intolerant Patients for the Treatment of Methicillin-Susceptible Staphylococcus aureus Infections.
    Gandhi AM; Shah MD; Donohue LE; Cox HL; Eby JC
    Clin Infect Dis; 2021 Nov; 73(9):1650-1655. PubMed ID: 33905485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Relationship Between Antibiotic Agent and Mortality in Patients With Febrile Neutropenia due to Staphylococcal Bloodstream Infection: A Multicenter Cohort Study.
    Aleissa MM; Gonzalez-Bocco IH; Zekery-Saad S; Kubiak DW; Zhang EM; Signorelli J; Hammond SP; Mohareb AM; Luskin MR; Manne-Goehler J; Marty FM
    Open Forum Infect Dis; 2022 Aug; 9(8):ofac306. PubMed ID: 35949404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daptomycin Plus Oxacillin for Persistent Methicillin-Susceptible
    Kufel WD; Zagoria Z; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
    Ann Pharmacother; 2024 Apr; 58(4):360-365. PubMed ID: 37542415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Ceftriaxone in the Treatment of Methicillin-Susceptible
    Ganguly A; de la Flor C; Alvarez K; Brown LS; Mang NS; Smartt J; King H; Perl TM; Filizola H; Bhavan KP
    Ann Pharmacother; 2023 Apr; 57(4):425-431. PubMed ID: 35942602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia.
    Yetmar ZA; Khodadadi RB; Go JR; Chesdachai S; Abu Saleh OM
    Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):423-430. PubMed ID: 36800065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible
    La YJ; Kim HR; Oh DH; Ahn JY; Kim YC
    Yonsei Med J; 2022 Jul; 63(7):611-618. PubMed ID: 35748072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
    Agnello S; Wardlow LC; Reed E; Smith JM; Coe K; Day SR
    Int J Antimicrob Agents; 2021 Aug; 58(2):106363. PubMed ID: 34033912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
    Blumenthal KG; Shenoy ES; Huang M; Kuhlen JL; Ware WA; Parker RA; Walensky RP
    PLoS One; 2016; 11(7):e0159406. PubMed ID: 27438379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
    McConeghy KW; Bleasdale SC; Rodvold KA
    Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.
    McDanel JS; Perencevich EN; Diekema DJ; Herwaldt LA; Smith TC; Chrischilles EA; Dawson JD; Jiang L; Goto M; Schweizer ML
    Clin Infect Dis; 2015 Aug; 61(3):361-7. PubMed ID: 25900170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic investigation and clinical correlates of the
    Petersiel N; Giulieri S; Daniel DS; Fan S-H; Ersoy SC; Davis JS; Bayer AS; Howden BP; Tong SYC;
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0021824. PubMed ID: 38837393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of trials comparing cefazolin to antistaphylococcal penicillins in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia.
    Rindone JP; Mellen CK
    Br J Clin Pharmacol; 2018 Jun; 84(6):1258-1266. PubMed ID: 29600576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic Impact of a Preferred Anti-Methicillin Susceptible Staphylococcus aureus Protocol.
    Gauthier TP; Carrasquillo M; Lichtenberger P; Baracco G
    Clin Infect Dis; 2018 Apr; 66(9):1483-1484. PubMed ID: 29211820
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
    Dilworth TJ; Sliwinski J; Ryan K; Dodd M; Mercier RC
    Antimicrob Agents Chemother; 2014; 58(2):1028-33. PubMed ID: 24277036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.